CCM
ABBV icon

Cribstone Capital Management’s AbbVie ABBV Stock Holding History

Cribstone Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$1.22M Sell
7,558
-506
-6% -$77.6K 0.71% 42
2022
Q3 		$1.08M Sell
8,064
-148
-2% -$21.2K 0.67% 44
2022
Q2 		$1.26M Sell
8,212
-17
-0.2% -$2.6K 0.77% 37
2022
Q1 		$1.33M Sell
8,229
-988
-11% -$144K 0.73% 40
2021
Q4 		$1.25M Buy
9,217
+71
+0.8% +$8.39K 0.69% 38
2021
Q3 		$987K Buy
9,146
+1,423
+18% +$163K 0.59% 46
2021
Q2 		$870K Buy
7,723
+227
+3% +$25.6K 0.53% 51
2021
Q1 		$811K Buy
7,496
+2,838
+61% +$304K 0.53% 51
2020
Q4 		$499K Buy
4,658
+1,030
+28% +$99K 0.34% 66
2020
Q3 		$318K Sell
3,628
-3
-0.1% -$282 0.26% 75
2020
Q2 		$356K Buy
3,631
+3,441
+1,811% +$303K 0.29% 73
2020
Q1 		$14K Sell
190
-300
-61% -$25.6K 0.01% 186
2019
Q4 		$43K Sell
490
-1,867
-79% -$155K 0.04% 147
2019
Q3 		$178K Sell
2,357
-1,397
-37% -$95.8K 0.11% 119
2019
Q2 		$273K Sell
3,754
-125
-3% -$9.82K 0.15% 101
2019
Q1 		$313K Sell
3,879
-99
-2% -$8.1K 0.17% 90
2018
Q4 		$367K Sell
3,978
-83
-2% -$7.3K 0.19% 85
2018
Q3 		$384K Buy
4,061
+69
+2% +$6.54K 0.18% 90
2018
Q2 		$370K Hold
3,992
– – 0.18% 90
2018
Q1 		$378K Buy
3,992
+700
+21% +$76.9K 0.19% 89
2017
Q4 		$318K Sell
3,292
-151
-4% -$14.2K 0.15% 98
2017
Q3 		$306K Buy
3,443
+300
+10% +$22.8K 0.16% 86
2017
Q2 		$228K Sell
3,143
-200
-6% -$13.4K 0.12% 105
2017
Q1 		$219K Sell
3,343
-35
-1% -$2.2K 0.12% 106
2016
Q4 		$207K Sell
3,378
-494
-13% -$30.2K 0.13% 102
2016
Q3 		$237K Buy
3,872
+82
+2% +$5.31K 0.15% 95
2016
Q2 		$235K Sell
3,790
-691
-15% -$42.1K 0.15% 98
2016
Q1 		$256K Sell
4,481
-141
-3% -$7.86K 0.21% 87
2015
Q4 		$273K Buy
+4,622
New +$266K 0.22% 82

Other funds holding ABBV

AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cribstone Capital Management's ABBV Position: Q4 2022 in Review

Cribstone Capital Management reduced its AbbVie (ABBV) stake by 6.3% in Q4 2022, selling an estimated $77.6K and leaving 7,558 shares worth $1.22M. The position accounts for 0.71% of the portfolio, ranked #42.

Cribstone Capital Management first reported a position in ABBV in Q4 2015 and has held it in 29 quarters since. The position peaked at $1.33M in Q1 2022. 3,167 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.

  • Cribstone Capital Management held 7,558 shares of AbbVie worth $1.22M as of Q4 2022.
  • Cribstone Capital Management sold 506 AbbVie shares in Q4 2022, an estimated $77.6K.
  • AbbVie made up 0.71% of Cribstone Capital Management's portfolio in Q4 2022, its #42 holding.
  • Cribstone Capital Management first reported a position in AbbVie in Q4 2015 and has held it in 29 quarters since.
  • Cribstone Capital Management's AbbVie position peaked at $1.33M in Q1 2022.
  • 3,167 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.

Based on Cribstone Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.